Drug research

Lurbinectedin

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Zepzelca

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid TumorsNCT05126433	Jazz Pharmaceuticals	Phase 2	Terminated	2023-12-20Actual
A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLCNCT07459634	Jazz Pharmaceuticals	Phase 2	Recruiting	2028-01-31Estimated

Jazz PharmaceuticalsTerminatedPrimary completion: 2023-12-20 · Actual

Trial details

Jazz PharmaceuticalsRecruitingPrimary completion: 2028-01-31 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.